[ET Net News Agency, 27 January 2026] CSPC PHARMA (01093) rose 3% to HK$9.89.
It hits an intra-day high of HK$9.91, breaking above the 10-D SMA of HK$9.78, and an
intra-day low of HK$9.49. The total shares traded was 54.02 million, with a value of
HK$521.68m. The active buy/sell ratio is 54:46, with net buying turnover of HK$41.13m.
J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$18.37m,
with volume weighted average price of HK$9.619. BARCLAYS CAPITAL ASIA accounts for
greatest net responsive selling turnover of HK$17.47m, with volume weighted average price
of HK$9.652.
The Hang Seng Index now rose 293 points, or 1.1% to 27,058; the Hang Seng China
Enterprises Index now rose 80 points, or 0.9% to 9,227.

Basic Information
=================

----------------------------------
Nominal 9.890 % Chg +3.02%
High 9.910 Low 9.490
Shares Tr 54.02m Turnover 521.68m
10-D SMA 9.780 %H.V 30.095
20-D SMA 9.380 VWAP 9.658
50-D SMA 8.459 RSI14 67.148
----------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 54:46, with net buying
turnover of HK$41.13m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSPC PHARMA (01093) 9.89 +3.02
SINO BIOPHARM (01177) 6.60 +1.23
HENGRUI PHARMA (01276) 70.05 -2.64
3SBIO (01530) 24.06 +1.95
INNOVENT BIO (01801) 82.10 +0.55
WUXI BIO (02269) 38.06 -0.42
WUXI APPTEC (02359) 114.60 +0.35
HANSOH PHARMA (03692) 38.90 -3.33
BEONE MEDICINES (06160) 201.60 -0.20
AKESO (09926) 113.70 +1.43
-----------------------------------------------
(ed)